Sarolaner

目录号: GC34774纯度: >98.00%同义词: 1-[5'-[(5S)-5-(3,5-二氯-4-氟苯基)-4,5-二氢-5-(三氟甲基)-3-异恶唑基]螺[氮杂环丁烷-3,1'(3'H)-异苯并呋喃]-1-基]-2-(甲基磺酰基)乙酮,PF-6450567
Sarolaner是一种口服的、广谱的异噁唑啉类犬体外寄生虫杀灭剂。

Sarolaner
Cas No.: 1398609-39-6
规格价格库存数量操作
1mg¥266.00现货
1
5mg¥700.00现货
1
10mg¥1,120.00现货
1
25mg¥2,345.00现货
1
50mg¥3,780.00现货
1
10mM (in 1mL DMSO)¥895.00现货
1

文献被引

本产品暂无引用记录;以下为 GlpBio 产品在 Nature / Cell / Science 等顶刊的客户引用样例
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

产品描述 Description

Sarolaner is an orally administered, broad-spectrum, isoxazoline ectoparasiticide for dogs [1].

In vitro sarolaner demonstrated an LC80 of 0.3μg/mL against C. felis and an LC100 of 0.003μg/mL against O. turicata [1].

In vivo efficacy (> 99%) of sarolaner was demonstrated against fleas and ticks for at least one month from a single oral dose of between 1.25 and 5mg/kg in dogs [1]. Sarolaner at an oral dose of 2mg/kg was highly effective in reducing the live mite counts in dogs with a natural infestation of Demodex spp. and an induced infestation of O. cynotis [2]. Oral administration of sarolaner at 2–4mg/kg achieved >95% efficacy against the feline fur mite Lynxacarus radovskyi at Day 30 post-treatment [3].

References:
[1] McTier, Tom L., et al. "Discovery of sarolaner: A novel, orally administered, broad-spectrum, isoxazoline ectoparasiticide for dogs." Veterinary Parasitology 222 (2016): 3-11.
[2] Six, Robert H., et al. "Efficacy of sarolaner, a novel oral isoxazoline, against two common mite infestations in dogs: Demodex spp. and Otodectes cynotis." Veterinary Parasitology 222 (2016): 62-66.
[3] Campos, Diefrey R., et al. "Efficacy of oral sarolaner against Lynxacarus radovskyi in naturally infested cats." Veterinary Dermatology 31.5 (2020): 355-e92.

Sarolaner是一种口服的、广谱的异噁唑啉类犬体外寄生虫杀灭剂 [1]

体外实验中,Sarolaner对跳蚤(Ctenocephalides felis)的LC80为 0.3μg/mL,对软蜱(Ornithodoros turicata)的LC100为 0.003μg/mL [1]

体内试验中,Sarolaner (1.25 and 5mg/kg)给狗口服,对跳蚤和蜱虫的杀灭效果(> 99%)至少能持续一个月[1]。口服剂量为 2mg/kg 的Sarolaner能有效降低自然感染Demodex spp.和人为感染O. cynotis的犬体内活螨的数量 [2]。给猫单次口服Sarolaner 2-4mg/kg,治疗后 30 天对猫毛螨 Lynxacarus radovskyi 的清除效果达到 95% 以上 [3]

实验参考方法 Experimental Reference Method

Animal experiment [1]:

Animal models

Beagles dogs

Preparation Method

On Day-7, each dog was infested with Rhipicephalus sanguineus. On Day-5, the ticks on each dog were counted, dogs were ranked by descending tick count into blocks, and randomly allocated within blocks to two treatment groups of eight dogs each. On Day-2, the dogs were weighed and infested with R. sanguineus and Dermacentor reticulatus ticks. On Day-1, the dogs were infested with fleas. On Day 0, each animal was treated via oral gavage at 0.5mL/kg body weight with either placebo control or sarolaner solution (5mg/mL) to provide a dose of 2.5mg/kg. A tetraglycol/solutol solution base was used to formulate the sarolaner. Dogs were observed for general health and any reaction to treatment approximately 1, 3 and 6h after treatment on Day 0, then once daily for the remainder of the study. On Day 2, each dog was examined and combed to count and remove fleas and ticks. Subsequently, all animals were infested with R. sanguineus and D. reticulatus on Days 5, 12, 19, 25 and 33, and with fleas on Days 6, 13, 20, 26 and 34. All dogs were examined, combed and parasite counted on Days 7, 14, 21, 27 and 35.

Dosage form

2.5mg/kg; oral gavage; once

Applications

Sarolaner was 100% efficacious at 48h after treatment and against subsequent infestations through Day 35.

References:
[1]. McTier, Tom L., et al. "Discovery of sarolaner: A novel, orally administered, broad-spectrum, isoxazoline ectoparasiticide for dogs." Veterinary Parasitology 222 (2016): 3-11.

产品文档 Product Documents

Purity:>98.00%

化学性质Chemical Properties

CAS 号
1398609-39-6
同义词
1-[5'-[(5S)-5-(3,5-二氯-4-氟苯基)-4,5-二氢-5-(三氟甲基)-3-异恶唑基]螺[氮杂环丁烷-3,1'(3'H)-异苯并呋喃]-1-基]-2-(甲基磺酰基)乙酮,PF-6450567
SMILES
O=S(CC(N1CC2(OCC3=C2C=CC(C4=NO[C@](C(F)(F)F)(C5=CC(Cl)=C(F)C(Cl)=C5)C4)=C3)C1)=O)(C)=O
分子式
C23H18Cl2F4N2O5S
分子量
581.36 g/mol
溶解性
DMSO : 150 mg/mL (258.02 mM);Water : < 0.1 mg/mL (insoluble)
保存条件
Store at 4°C, sealed storage, away from moisture
General tips
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至 37°C,然后在超声波浴中震荡一段时间。
Shipping Condition
评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备 RT,或根据请求配备蓝冰。

计算工具摩尔浓度 / 稀释 / 分子量 / 单位换算 / 体内配方 / 溶解度

g/mol